FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the Life Science market, today announced the commercial launch of BalanCD HEK293 Perfusion A.

The medium, which is designed for high density perfusion culture, is available in a variety of media package options for continuous processing.

The first-ever multicenter study of Hypothermic Oxygenated Perfusion (HOPE) in pediatric liver transplantation—using any machine perfusion device— was presented today at the 13th Congress of the Inter ...

New Modes Are Beginning to Gain Ground on Fed-batch Strategy The therapeutic success of highly efficacious complex biologicals that are almost exclusively produced in cell culture such as antibodies ...

WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announced today the completion of the world’s first donor kidney ...

WALTHAM, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Paragonix Technologies, a leader in advanced organ preservation and transplant logistics, reports an extraordinary case at the Tampa General Hospital ...

Keystone is expected to generate approximately $65 million of revenue and approximately $13 million of Adjusted EBITDA(1) in the full-year 2025, ...

Warsaw, Ind.-based OrthoPediatrics Corp. has entered into a distribution partnership with Canada-based MY01 to expand access to its continuous perfusion sensing technology platform for diagnosing limb ...